The University of Chicago Header Logo

Peter Riedell

Concepts (164)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lymphoma, Large B-Cell, Diffuse
21
2024
154
5.800
Why?
Immunotherapy, Adoptive
24
2024
189
5.640
Why?
Antigens, CD19
13
2024
42
2.580
Why?
Hematopoietic Stem Cell Transplantation
12
2024
885
2.340
Why?
Lymphoma, Mantle-Cell
4
2024
37
1.990
Why?
Lymphoma, Follicular
5
2024
73
1.650
Why?
Lymphoma, Non-Hodgkin
5
2023
261
1.350
Why?
Lymphoma, B-Cell
5
2022
105
1.250
Why?
Transplantation, Autologous
7
2024
342
1.250
Why?
Standard of Care
2
2024
65
0.960
Why?
Biological Products
5
2024
149
0.910
Why?
Oncologists
1
2023
36
0.890
Why?
Receptors, Antigen, T-Cell
7
2024
394
0.820
Why?
Central Nervous System Neoplasms
4
2024
85
0.810
Why?
Blood Component Removal
1
2020
24
0.750
Why?
Proto-Oncogene Proteins c-myc
2
2018
126
0.750
Why?
Neoplasm Recurrence, Local
13
2024
1354
0.750
Why?
Jehovah's Witnesses
1
2021
20
0.750
Why?
Proto-Oncogene Proteins c-bcl-2
2
2018
196
0.720
Why?
Lymphoma
3
2024
264
0.720
Why?
Transplantation Conditioning
3
2021
374
0.710
Why?
Humans
56
2024
88709
0.660
Why?
Antineoplastic Combined Chemotherapy Protocols
7
2023
2546
0.540
Why?
Antibodies, Monoclonal, Murine-Derived
3
2016
77
0.530
Why?
Retrospective Studies
11
2024
8931
0.510
Why?
Graft vs Host Disease
3
2023
359
0.480
Why?
Hepatitis B virus
1
2014
43
0.470
Why?
Hepatitis B
1
2014
75
0.450
Why?
Aged
21
2024
18984
0.450
Why?
B-Lymphocytes
1
2017
737
0.430
Why?
Geriatric Assessment
3
2024
182
0.410
Why?
Gene Expression Profiling
1
2017
1428
0.400
Why?
Remission Induction
5
2024
738
0.390
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2023
157
0.390
Why?
Adult
18
2024
26386
0.370
Why?
Middle Aged
19
2024
25737
0.370
Why?
Antineoplastic Agents, Immunological
2
2023
195
0.350
Why?
Cell- and Tissue-Based Therapy
4
2023
50
0.340
Why?
Prognosis
4
2024
3750
0.340
Why?
Antineoplastic Agents
3
2023
2410
0.320
Why?
Male
21
2024
42063
0.300
Why?
T-Lymphocytes
4
2021
1222
0.280
Why?
Sarcopenia
2
2016
13
0.270
Why?
Female
20
2024
45822
0.270
Why?
Antibodies, Bispecific
1
2024
26
0.240
Why?
Oleic Acids
1
2023
26
0.230
Why?
Tumor Lysis Syndrome
1
2023
9
0.230
Why?
Adolescent
4
2024
9190
0.230
Why?
Candidiasis
1
2023
37
0.220
Why?
Survival Analysis
3
2023
1533
0.220
Why?
Fluorodeoxyglucose F18
1
2023
142
0.210
Why?
Rituximab
4
2016
119
0.210
Why?
Veterans
4
2016
83
0.210
Why?
Tumor Burden
1
2023
308
0.200
Why?
Hodgkin Disease
1
2023
181
0.200
Why?
Young Adult
5
2024
6257
0.200
Why?
Thrombocytopenia
1
2022
187
0.190
Why?
5-Methylcytosine
1
2022
117
0.190
Why?
United States
7
2023
6905
0.180
Why?
Recurrence
4
2024
1136
0.180
Why?
Antibodies, Monoclonal, Humanized
2
2023
965
0.180
Why?
Cladribine
1
2019
35
0.170
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2020
48
0.170
Why?
CD8-Positive T-Lymphocytes
1
2023
592
0.170
Why?
Carcinoma
1
2023
442
0.170
Why?
Hematologic Neoplasms
1
2023
339
0.170
Why?
Patient Selection
2
2019
682
0.160
Why?
Interdisciplinary Communication
1
2019
130
0.160
Why?
Neoplasms
2
2023
3020
0.150
Why?
Preoperative Care
1
2019
395
0.150
Why?
Disease Management
1
2019
328
0.150
Why?
Patient Care Team
1
2019
283
0.140
Why?
Translocation, Genetic
1
2017
266
0.140
Why?
Cyclophosphamide
4
2021
299
0.140
Why?
Obesity, Abdominal
1
2016
8
0.140
Why?
Multiple Myeloma
1
2020
330
0.140
Why?
Body Composition
1
2016
71
0.130
Why?
Up-Regulation
1
2018
727
0.130
Why?
Maximum Tolerated Dose
1
2016
272
0.130
Why?
Stem Cell Transplantation
3
2021
188
0.130
Why?
Pneumonia, Viral
1
2020
319
0.120
Why?
Anthracyclines
1
2015
38
0.120
Why?
Coronavirus Infections
1
2020
304
0.120
Why?
Survivors
1
2016
232
0.120
Why?
Doxorubicin
4
2016
298
0.120
Why?
Febrile Neutropenia
1
2014
14
0.120
Why?
Treatment Outcome
6
2024
8166
0.120
Why?
Pandemics
1
2020
766
0.120
Why?
Aged, 80 and over
5
2024
6753
0.110
Why?
Heart Failure
1
2023
1173
0.110
Why?
Venous Thromboembolism
1
2016
159
0.110
Why?
Leukemia, Myeloid, Acute
1
2019
785
0.110
Why?
Transplantation, Homologous
3
2020
991
0.110
Why?
Clinical Trials as Topic
1
2018
1146
0.110
Why?
Gene Expression Regulation, Neoplastic
1
2018
1264
0.110
Why?
Bridged Bicyclo Compounds, Heterocyclic
2
2023
88
0.110
Why?
Time Factors
1
2021
5308
0.100
Why?
Vincristine
3
2016
112
0.100
Why?
Prednisone
3
2016
258
0.090
Why?
Body Mass Index
1
2014
763
0.090
Why?
Antiviral Agents
1
2014
474
0.090
Why?
Pilot Projects
2
2021
864
0.080
Why?
Antibodies, Monoclonal
1
2014
1399
0.080
Why?
Prospective Studies
3
2023
4250
0.070
Why?
Follow-Up Studies
2
2024
3647
0.070
Why?
Lymphoma, Extranodal NK-T-Cell
1
2024
4
0.060
Why?
Dairy Products
1
2023
11
0.060
Why?
Red Meat
1
2023
10
0.060
Why?
Lymphoma, T-Cell
1
2024
55
0.060
Why?
Fatty Acids, Volatile
1
2023
32
0.060
Why?
Milk
1
2023
53
0.060
Why?
Cyclic AMP Response Element-Binding Protein
1
2023
68
0.060
Why?
Sheep
1
2023
250
0.060
Why?
Cyclic AMP-Dependent Protein Kinases
1
2023
108
0.060
Why?
Leukocyte Count
1
2023
223
0.060
Why?
Troponin
1
2023
24
0.060
Why?
Cattle
1
2023
375
0.060
Why?
Cyclic AMP
1
2023
274
0.050
Why?
Melphalan
1
2023
98
0.050
Why?
Outpatients
1
2023
99
0.050
Why?
Immunocompromised Host
1
2023
141
0.050
Why?
Killer Cells, Natural
1
2024
275
0.050
Why?
C-Reactive Protein
1
2023
192
0.050
Why?
Interleukin-6
1
2023
260
0.050
Why?
Thiotepa
1
2021
32
0.050
Why?
Histiocytes
1
2021
22
0.050
Why?
B7-H1 Antigen
1
2023
271
0.050
Why?
Sulfonamides
1
2023
317
0.050
Why?
Incidence
2
2016
1588
0.050
Why?
Central Nervous System
1
2021
153
0.050
Why?
Risk Factors
2
2024
5442
0.040
Why?
Health Planning Guidelines
1
2019
22
0.040
Why?
Survival Rate
1
2024
1874
0.040
Why?
Chimerism
1
2020
37
0.040
Why?
Communicable Disease Control
1
2020
50
0.040
Why?
Filgrastim
1
2019
57
0.040
Why?
Hydrazines
1
2019
31
0.040
Why?
Health Care Rationing
1
2020
83
0.040
Why?
Health Plan Implementation
1
2019
56
0.040
Why?
Mice
2
2023
11718
0.040
Why?
Cytarabine
1
2019
219
0.040
Why?
Triazoles
1
2019
102
0.040
Why?
Animals
3
2023
27260
0.040
Why?
Drug Resistance, Neoplasm
1
2021
615
0.040
Why?
Epigenesis, Genetic
1
2022
504
0.040
Why?
Palliative Care
1
2019
263
0.040
Why?
Clinical Decision-Making
1
2019
277
0.040
Why?
Steroids
1
2018
174
0.040
Why?
Tissue Donors
1
2020
489
0.030
Why?
Abdominal Fat
1
2016
13
0.030
Why?
Biomarkers
1
2023
1751
0.030
Why?
Subcutaneous Fat
1
2016
22
0.030
Why?
Neutropenia
1
2016
216
0.030
Why?
Cohort Studies
1
2021
2844
0.030
Why?
Antibiotics, Antineoplastic
1
2015
116
0.030
Why?
Proportional Hazards Models
1
2016
848
0.030
Why?
Muscle, Skeletal
1
2016
465
0.030
Why?
Practice Guidelines as Topic
1
2020
1039
0.030
Why?
Mice, Inbred C57BL
1
2019
3201
0.030
Why?
Longitudinal Studies
1
2016
1066
0.030
Why?
Hospitalization
1
2016
871
0.020
Why?
Mutation
1
2022
4121
0.020
Why?
Tomography, X-Ray Computed
1
2016
2644
0.020
Why?
Magnetic Resonance Imaging
1
2018
3440
0.020
Why?
Riedell's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (164)
Explore
_
Co-Authors (47)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_